OncoMatch/Clinical Trials/NCT07782944
CD38 Targeted -PET/ CT for Multiple Myeloma
Is NCT07782944 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for multiple myeloma (mm), lymphoma, large b-cell, diffuse (dlbcl), lymphoma.
The objective of the study is to construct a noninvasive approach CD38 targeted PET/CT to detect tumor lesions in patients with Multiple Myeloma and to compare with FDG PET/CT.
Check if I qualifyExtracted eligibility criteria
Cancer type
Multiple Myeloma
Diffuse Large B-Cell Lymphoma
Non-Hodgkin Lymphoma
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07782944 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify